Kidswell Bio Corporation's market cap is currently ¥4.23B. The company's EPS TTM is ¥-22.725; its P/E ratio is ―; Kidswell Bio Corporation is scheduled to report earnings on February 12, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Income Statement
Total Revenue	¥ 2.43B	¥ 2.78B	¥ 1.57B	¥ 996.54M	¥ 1.08B
Gross Profit	¥ 1.04B	¥ 1.53B	¥ 1.02B	¥ 876.97M	¥ 423.00M
Operating Income	¥ -1.34B	¥ -550.93M	¥ -651.14M	¥ -969.69M	¥ -1.16B
EBITDA	¥ -1.38B	¥ -620.45M	¥ -531.89M	¥ -983.00M	¥ -7.31B
Net Income	¥ -1.42B	¥ -657.43M	¥ -550.86M	¥ -1.00B	¥ -7.32B
Balance Sheet
Cash & Short-Term Investments	¥ 2.23B	¥ 1.07B	¥ 1.16B	¥ 1.46B	¥ 2.03B
Total Assets	¥ 5.09B	¥ 3.89B	¥ 3.47B	¥ 3.93B	¥ 3.59B
Total Debt	¥ 2.58B	¥ 1.95B	¥ 700.00M	¥ 1.10B	¥ 1.23B
Net Debt	¥ 343.59M	¥ 882.84M	¥ -460.93M	¥ -361.16M	¥ -807.58M
Total Liabilities	¥ 4.25B	¥ 2.66B	¥ 1.77B	¥ 2.32B	¥ 2.10B
Stockholders' Equity	¥ 831.47M	¥ 1.23B	¥ 1.70B	¥ 1.61B	¥ 1.49B
Cash Flow
Free Cash Flow	¥ -453.63M	¥ -1.42B	¥ -1.17B	¥ -1.27B	¥ -3.26M
Operating Cash Flow	¥ -453.63M	¥ -1.42B	¥ -1.17B	¥ -1.27B	¥ -1.32M
Investing Cash Flow	¥ 0.00	¥ -28.82M	¥ 526.51M	¥ -22.29M	¥ -137.00K
Financing Cash Flow	¥ 1.62B	¥ 1.36B	¥ 369.08M	¥ 718.35M	¥ 1.22M

Currency in JPY

Kidswell Bio Corporation Earnings and Revenue History

Income Statement >

Kidswell Bio Corporation Debt to Assets

Balance Sheet >

Kidswell Bio Corporation Cash Flow

Cash Flow >

Kidswell Bio Corporation Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing